Bogart D B, Bogart M A, Miller J T, Farrar M W, Barr W K, Montgomery M A
Northland Cardiology, North Kansas City, MO 64116, USA.
Cathet Cardiovasc Diagn. 1995 Jan;34(1):8-13. doi: 10.1002/ccd.1810340304.
This report describes a prospective randomized trial of 503 patients who underwent a cardiac catheterization or interventional procedure at a single institution. In an effort to study femoral complications postprocedure, we evaluated three methods of femoral artery hemostasis as well as 38 variables that were felt to potentially relate to local complications. Only a marginally significant relationship between the hemostasis method and complication rate was found. The factors that contributed to femoral artery complications were: restarting heparin postsheath removal, number of procedures done during one hospitalization, noncompliance of the patient with bedrest after the procedure, number of arterial punctures to initiate the procedure, and preprocedure treatment with corticosteroids.
本报告描述了一项针对503例在单一机构接受心脏导管插入术或介入手术患者的前瞻性随机试验。为了研究术后股动脉并发症，我们评估了三种股动脉止血方法以及38个被认为可能与局部并发症相关的变量。仅发现止血方法与并发症发生率之间存在微弱的显著关系。导致股动脉并发症的因素包括：拔除鞘管后重新使用肝素、一次住院期间进行的手术数量、患者术后不遵守卧床休息规定、开始手术时的动脉穿刺次数以及术前使用皮质类固醇治疗。
